Back to results
TerminatedPhase 2

Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

NCT00916617

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Banner Alzheimer's Institute

Phoenix, Arizona, United States

+15 additional locations

View on ClinicalTrials.gov
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab — TrialFind